Guidelines and Treatment Recommendations





Additional Readings

  • Center for Disease Control and Prevention. Chronic disease prevention and health promotion.
  • Segal AR, et al. Insulin: making sense of current options. Endocrinol Metab Clin North Am. 2016;45(4):845-874.
  • Roth EG, et al. Diabetes and the motivated patient: Understanding perlocutionary effect in health communication. Health Commun. 2017;32(4):502-508.
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
  • Baptista DR, et al. The chronic care model for type 2 diabetes: a systematic review.
    Diabetol Metab Syndr. 2016;8:7.
  • Hewston P, Deshpande N. The short version of the activities-specific balance confidence scale for older adults with diabetes-convergent, discriminant and concurrent validity: a pilot study. Can J Diabetes. 2017;41(3):266-272.
  • American Diabetes Association. Strategies for improving care.
    Diabetes Care. 2016;39(suppl 1):S6-S12.
  • Micha R, Peñalvo JL, Cudhea F, et al. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA. 2017;317(9):912-924.
  • Otto MC, Afshin A, Micha R, et al; Global Burden of Diseases, Injuries, and Risk Factors Metabolic Risk Factors of Chronic Diseases Expert Group; Nutrition and Chronic Diseases Expert Group (NutriCoDE). The impact of dietary and metabolic risk factors on cardiovascular diseases and type 2 diabetes mortality in Brazil. PLoS One. 2016;11(3):e0151503.
  • Yang CJ, Hsu HY, Lu CH, et al. Do we underestimate influences of diabetic mononeuropathy or polyneuropathy on hand functional performance and life quality? J Diabetes Investig. 2018;9(1):179-185.
  • Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig. 2017;8(5):646-655.
  • Strain WD, Agarwal AS, Paldánius PM. Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study. Aging (Albany NY). 2017;9(3):769-777.
  • Brahimaj A, Ligthart S, Ghanbari M, et al. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam Study. Eur J Epidemiol. 2017;32(3):217-226.
  • Hutchison AT, Wittert GA, Heilbronn LK. Matching meals to body clocks-impact on weight and glucose metabolism. Nutrients. 2017;9(3):E222.
  • Wise J. Complications are more common in young people with type 2 diabetes than type 1. BMJ. 2017;356:j1082.
  • Kuhn A, Park J, Ghazi A, Aroda VR. Intensifying treatment beyond monotherapy in type 2 diabetes mellitus: where do newer therapies fit? Curr Cardiol Rep. 2017;19(3):25.
Font Size